The global In-Silico Drug Discovery market size is predicted to grow from US$ 2695 million in 2025 to US$ 5419 million in 2031; it is expected to grow at a CAGR of 12.3% from 2025 to 2031.
In silico also known as computer-aided drug design is a process by which the drug is design or discovered by using computational methods. Drug discovery process is carried out to identify new drug molecules that can attach to a specific target. This method of identifying drugs is based on computation and the entire process is considered linear and consecutive. Various factors make in-silico drug discovery method more productive and a wise approach in comparison to earlier drug discovery methods used for the drug development process. In-silico drug design can play a significant role in all stages of drug development – from the initial lead designing to final stage clinical development.
The main In-Silico Drug Discovery players include Charles River, Certara USA, Inc., Evotec, etc. The top three In-Silico Drug Discovery players account for approximately 36% of the total global market. In terms of type, Consultancy as a Service is the largest segment, with a share about 41%. And in terms of Application, the largest application is Contract Research Organization, followed by Pharmaceutical Industry.
The “In-Silico Drug Discovery Industry Forecast” looks at past sales and reviews total world In-Silico Drug Discovery sales in 2024, providing a comprehensive analysis by region and market sector of projected In-Silico Drug Discovery sales for 2025 through 2031. With In-Silico Drug Discovery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In-Silico Drug Discovery industry.
This Insight Report provides a comprehensive analysis of the global In-Silico Drug Discovery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on In-Silico Drug Discovery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global In-Silico Drug Discovery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In-Silico Drug Discovery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In-Silico Drug Discovery.
This report presents a comprehensive overview, market shares, and growth opportunities of In-Silico Drug Discovery market by product type, application, key players and key regions and countries.
Segmentation by Type:
Software as a Service (Cloud)
Consultancy as a Service
Software
Segmentation by Application:
Contract Research Organization
Pharmaceutical Industry
Academic and Research Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River
Certara USA, Inc.
Evotec
Dassault System (Biovia)
Albany Molecular Research Inc. (AMRI)
Selvita
Schrödinger, Inc.
GVK BIO
OpenEye Scientific Software
Chemical Computing Group (CCG)
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global In-Silico Drug Discovery Market Size (2020-2031)
2.1.2 In-Silico Drug Discovery Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for In-Silico Drug Discovery by Country/Region (2020, 2024 & 2031)
2.2 In-Silico Drug Discovery Segment by Type
2.2.1 Software as a Service (Cloud)
2.2.2 Consultancy as a Service
2.2.3 Software
2.3 In-Silico Drug Discovery Market Size by Type
2.3.1 In-Silico Drug Discovery Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global In-Silico Drug Discovery Market Size Market Share by Type (2020-2025)
2.4 In-Silico Drug Discovery Segment by Application
2.4.1 Contract Research Organization
2.4.2 Pharmaceutical Industry
2.4.3 Academic and Research Institutes
2.4.4 Others
2.5 In-Silico Drug Discovery Market Size by Application
2.5.1 In-Silico Drug Discovery Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global In-Silico Drug Discovery Market Size Market Share by Application (2020-2025)
3 In-Silico Drug Discovery Market Size by Player
3.1 In-Silico Drug Discovery Market Size Market Share by Player
3.1.1 Global In-Silico Drug Discovery Revenue by Player (2020-2025)
3.1.2 Global In-Silico Drug Discovery Revenue Market Share by Player (2020-2025)
3.2 Global In-Silico Drug Discovery Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 In-Silico Drug Discovery by Region
4.1 In-Silico Drug Discovery Market Size by Region (2020-2025)
4.2 Global In-Silico Drug Discovery Annual Revenue by Country/Region (2020-2025)
4.3 Americas In-Silico Drug Discovery Market Size Growth (2020-2025)
4.4 APAC In-Silico Drug Discovery Market Size Growth (2020-2025)
4.5 Europe In-Silico Drug Discovery Market Size Growth (2020-2025)
4.6 Middle East & Africa In-Silico Drug Discovery Market Size Growth (2020-2025)
5 Americas
5.1 Americas In-Silico Drug Discovery Market Size by Country (2020-2025)
5.2 Americas In-Silico Drug Discovery Market Size by Type (2020-2025)
5.3 Americas In-Silico Drug Discovery Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC In-Silico Drug Discovery Market Size by Region (2020-2025)
6.2 APAC In-Silico Drug Discovery Market Size by Type (2020-2025)
6.3 APAC In-Silico Drug Discovery Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe In-Silico Drug Discovery Market Size by Country (2020-2025)
7.2 Europe In-Silico Drug Discovery Market Size by Type (2020-2025)
7.3 Europe In-Silico Drug Discovery Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa In-Silico Drug Discovery by Region (2020-2025)
8.2 Middle East & Africa In-Silico Drug Discovery Market Size by Type (2020-2025)
8.3 Middle East & Africa In-Silico Drug Discovery Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global In-Silico Drug Discovery Market Forecast
10.1 Global In-Silico Drug Discovery Forecast by Region (2026-2031)
10.1.1 Global In-Silico Drug Discovery Forecast by Region (2026-2031)
10.1.2 Americas In-Silico Drug Discovery Forecast
10.1.3 APAC In-Silico Drug Discovery Forecast
10.1.4 Europe In-Silico Drug Discovery Forecast
10.1.5 Middle East & Africa In-Silico Drug Discovery Forecast
10.2 Americas In-Silico Drug Discovery Forecast by Country (2026-2031)
10.2.1 United States Market In-Silico Drug Discovery Forecast
10.2.2 Canada Market In-Silico Drug Discovery Forecast
10.2.3 Mexico Market In-Silico Drug Discovery Forecast
10.2.4 Brazil Market In-Silico Drug Discovery Forecast
10.3 APAC In-Silico Drug Discovery Forecast by Region (2026-2031)
10.3.1 China In-Silico Drug Discovery Market Forecast
10.3.2 Japan Market In-Silico Drug Discovery Forecast
10.3.3 Korea Market In-Silico Drug Discovery Forecast
10.3.4 Southeast Asia Market In-Silico Drug Discovery Forecast
10.3.5 India Market In-Silico Drug Discovery Forecast
10.3.6 Australia Market In-Silico Drug Discovery Forecast
10.4 Europe In-Silico Drug Discovery Forecast by Country (2026-2031)
10.4.1 Germany Market In-Silico Drug Discovery Forecast
10.4.2 France Market In-Silico Drug Discovery Forecast
10.4.3 UK Market In-Silico Drug Discovery Forecast
10.4.4 Italy Market In-Silico Drug Discovery Forecast
10.4.5 Russia Market In-Silico Drug Discovery Forecast
10.5 Middle East & Africa In-Silico Drug Discovery Forecast by Region (2026-2031)
10.5.1 Egypt Market In-Silico Drug Discovery Forecast
10.5.2 South Africa Market In-Silico Drug Discovery Forecast
10.5.3 Israel Market In-Silico Drug Discovery Forecast
10.5.4 Turkey Market In-Silico Drug Discovery Forecast
10.6 Global In-Silico Drug Discovery Forecast by Type (2026-2031)
10.7 Global In-Silico Drug Discovery Forecast by Application (2026-2031)
10.7.1 GCC Countries Market In-Silico Drug Discovery Forecast
11 Key Players Analysis
11.1 Charles River
11.1.1 Charles River Company Information
11.1.2 Charles River In-Silico Drug Discovery Product Offered
11.1.3 Charles River In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Charles River Main Business Overview
11.1.5 Charles River Latest Developments
11.2 Certara USA, Inc.
11.2.1 Certara USA, Inc. Company Information
11.2.2 Certara USA, Inc. In-Silico Drug Discovery Product Offered
11.2.3 Certara USA, Inc. In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Certara USA, Inc. Main Business Overview
11.2.5 Certara USA, Inc. Latest Developments
11.3 Evotec
11.3.1 Evotec Company Information
11.3.2 Evotec In-Silico Drug Discovery Product Offered
11.3.3 Evotec In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Evotec Main Business Overview
11.3.5 Evotec Latest Developments
11.4 Dassault System (Biovia)
11.4.1 Dassault System (Biovia) Company Information
11.4.2 Dassault System (Biovia) In-Silico Drug Discovery Product Offered
11.4.3 Dassault System (Biovia) In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Dassault System (Biovia) Main Business Overview
11.4.5 Dassault System (Biovia) Latest Developments
11.5 Albany Molecular Research Inc. (AMRI)
11.5.1 Albany Molecular Research Inc. (AMRI) Company Information
11.5.2 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Product Offered
11.5.3 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Albany Molecular Research Inc. (AMRI) Main Business Overview
11.5.5 Albany Molecular Research Inc. (AMRI) Latest Developments
11.6 Selvita
11.6.1 Selvita Company Information
11.6.2 Selvita In-Silico Drug Discovery Product Offered
11.6.3 Selvita In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Selvita Main Business Overview
11.6.5 Selvita Latest Developments
11.7 Schrödinger, Inc.
11.7.1 Schrödinger, Inc. Company Information
11.7.2 Schrödinger, Inc. In-Silico Drug Discovery Product Offered
11.7.3 Schrödinger, Inc. In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Schrödinger, Inc. Main Business Overview
11.7.5 Schrödinger, Inc. Latest Developments
11.8 GVK BIO
11.8.1 GVK BIO Company Information
11.8.2 GVK BIO In-Silico Drug Discovery Product Offered
11.8.3 GVK BIO In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 GVK BIO Main Business Overview
11.8.5 GVK BIO Latest Developments
11.9 OpenEye Scientific Software
11.9.1 OpenEye Scientific Software Company Information
11.9.2 OpenEye Scientific Software In-Silico Drug Discovery Product Offered
11.9.3 OpenEye Scientific Software In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 OpenEye Scientific Software Main Business Overview
11.9.5 OpenEye Scientific Software Latest Developments
11.10 Chemical Computing Group (CCG)
11.10.1 Chemical Computing Group (CCG) Company Information
11.10.2 Chemical Computing Group (CCG) In-Silico Drug Discovery Product Offered
11.10.3 Chemical Computing Group (CCG) In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Chemical Computing Group (CCG) Main Business Overview
11.10.5 Chemical Computing Group (CCG) Latest Developments
12 Research Findings and Conclusion
Ěý
Ěý
*If Applicable.
